Literature DB >> 11810992

[Dialysis Outcomes and Practice Patterns Study: data on the use of central venous catheters in chronic hemodialysis].

C Combe1, R L Pisoni, F K Port, E W Young, B Canaud, D L Mapes, P J Held.   

Abstract

Central venous catheters are widely used as vascular accesses for chronic haemodialysis. Different factors may lead to catheter use, whether clinical such as emergency dialysis, or related to practices specific to each dialysis unit or country. The Dialysis Outcomes and Practice Patterns Study is an observational study of more than 10,000 representative patients treated by haemodialysis followed over a two-year period in the United States, Japan, and in five European countries (France, Germany, Italy, Spain, United Kingdom). DOPPS data from the United States and Europe about catheters are reported in this paper. Catheter use is less frequent in Europe than in the US, both in incident and prevalent patients, and in patients who have been seen by a nephrologist in the pre-dialysis period. Tunneled and untunneled catheters are each associated with a significantly higher frequency of access infection compared to native arteriovenous fistulae and grafts. Patients with important comorbidities such as diabetes, cardiovascular diseases, malnutrition or dementia are more likely to be dialysed with tunneled catheters. Furthermore, patients initiating hemodialysis with a tunneled catheter display higher mortality risk compared to patients starting hemodialysis with a permanent access. In summary, DOPPS data indicate that central venous catheters are used for chronic haemodialysis in patients with a high level of morbidity, and that their utilisation is associated to an additional risk, particularly of infection, and to a lower survival for tunneled catheters. Appropriate care should limit the utilisation of central venous catheters to clinically undisputable indications.

Entities:  

Mesh:

Year:  2001        PMID: 11810992

Source DB:  PubMed          Journal:  Nephrologie        ISSN: 0250-4960


  10 in total

Review 1.  End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).

Authors:  Avi Dor; Mark V Pauly; Margaret A Eichleay; Philip J Held
Journal:  Int J Health Care Finance Econ       Date:  2007-09

2.  An experience of vascular access for hemodialysis in Brazil.

Authors:  Guilherme Centofanti; Eliane Y Fujii; Rafael N Cavalcante; Edgar Bortolini; Luiz Carlos de Abreu; Vitor E Valenti; Adilson C Pires; Hugo Macedo; Yumiko R Yamazaki; Soraya G Audi; José R Cisternas; João R Breda; Valdelias X Pereira; Edson N Fujiki; João A Correa
Journal:  Int Arch Med       Date:  2011-05-15

3.  A study of the response of elderly patients with end-stage renal disease to epoetin alfa or beta.

Authors:  Johann C B Nicholas
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

4.  Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patients.

Authors:  Yanhong Li; Joëlle Y Friedman; Betsy F O'Neal; Matthew J Hohenboken; Robert I Griffiths; Martin E Stryjewski; John P Middleton; Kevin A Schulman; Jula K Inrig; Vance G Fowler; Shelby D Reed
Journal:  Clin J Am Soc Nephrol       Date:  2008-12-31       Impact factor: 8.237

5.  Characteristics and 3-year mortality and infection rates among incident hemodialysis patients with a permanent catheter undergoing a first vascular access conversion.

Authors:  Yee-Yung Ng; Yen-Ni Hung; Shiao-Chi Wu; Po-Jen Ko
Journal:  Clin Exp Nephrol       Date:  2013-06-12       Impact factor: 2.801

6.  Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 study.

Authors:  Christian Combe; Johannes Mann; David Goldsmith; Frank Dellanna; Philippe Zaoui; Gérard London; Kris Denhaerynck; Andriy Krendyukov; Ivo Abraham; Karen MacDonald
Journal:  BMC Nephrol       Date:  2019-03-05       Impact factor: 2.388

7.  Substitution of citrate with tissue plasminogen activator (rt-PA) for catheter lock does not improve patency of tunnelled haemodialysis catheters in a randomised trial.

Authors:  Pavlina Richtrova; Jan Mares; Lukas Kielberger; Jan Klaboch; Jaromir Eiselt; Tomas Reischig
Journal:  BMC Nephrol       Date:  2021-01-28       Impact factor: 2.388

8.  Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study.

Authors:  Jean Ethier; David C Mendelssohn; Stacey J Elder; Takeshi Hasegawa; Tadao Akizawa; Takashi Akiba; Bernard J Canaud; Ronald L Pisoni
Journal:  Nephrol Dial Transplant       Date:  2008-05-29       Impact factor: 5.992

9.  Japanese haemodialysis anaemia management practices and outcomes (1999-2006): results from the DOPPS.

Authors:  Tadao Akizawa; Ronald L Pisoni; Takashi Akiba; Akira Saito; Shunichi Fukuhara; Yasushi Asano; Takeshi Hasegawa; Friedrich K Port; Kiyoshi Kurokawa
Journal:  Nephrol Dial Transplant       Date:  2008-06-24       Impact factor: 5.992

10.  Factors Affecting Hemodialysis Adequacy in Cohort of Iranian Patient with End Stage Renal Disease.

Authors:  Hosein Shahdadi; Abbas Balouchi; Zahra Sepehri; Hosein Rafiemanesh; Awad Magbri; Fereshteh Keikhaie; Ahmad Shahakzehi; Azizullah Arbabi Sarjou
Journal:  Glob J Health Sci       Date:  2016-08-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.